FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.24  |  FHIR Version n/a  User: [n/a]

1225211000001100: Co-proxamol 32.5mg/325mg tablets 30 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
22027701000001112 Co-proxamol 32.5mg/325mg tablets 30 tablet (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
22027801000001115 Co-proxamol 32.5mg/325mg tablets 30 tablet en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

3 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Co-proxamol 32.5mg/325mg tablets 30 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category Schedule 5 (CD Inv) true Inferred relationship Existential restriction modifier
Co-proxamol 32.5mg/325mg tablets 30 tablet Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Co-proxamol 32.5mg/325mg tablets 30 tablet Has VMP Co-proxamol 32.5mg/325mg tablets false Inferred relationship Existential restriction modifier
Co-proxamol 32.5mg/325mg tablets 30 tablet Has VMP Co-proxamol 32.5mg/325mg tablets true Inferred relationship Existential restriction modifier
Co-proxamol 32.5mg/325mg tablets 30 tablet Is pack of Product containing precisely dextropropoxyphene 32.5 milligram and paracetamol 325 milligram/1 each conventional release oral tablet false Inferred relationship Existential restriction modifier
Co-proxamol 32.5mg/325mg tablets 30 tablet Has active ingredient Dextropropoxyphene hydrochloride false Inferred relationship Existential restriction modifier
Co-proxamol 32.5mg/325mg tablets 30 tablet Has active ingredient Dextropropoxyphene false Inferred relationship Existential restriction modifier
Co-proxamol 32.5mg/325mg tablets 30 tablet Has active ingredient Paracetamol false Inferred relationship Existential restriction modifier
Co-proxamol 32.5mg/325mg tablets 30 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Co-proxamol 32.5mg/325mg tablets 30 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Co-proxamol 32.5mg/325mg tablets 30 tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Co-proxamol 32.5mg/325mg tablets 30 tablet Has VMP Product containing precisely dextropropoxyphene 32.5 milligram and paracetamol 325 milligram/1 each conventional release oral tablet false Inferred relationship Existential restriction modifier
Co-proxamol 32.5mg/325mg tablets 30 tablet Has specific active ingredient Paracetamol true Inferred relationship Existential restriction modifier
Co-proxamol 32.5mg/325mg tablets 30 tablet Has specific active ingredient Dextropropoxyphene hydrochloride true Inferred relationship Existential restriction modifier
Co-proxamol 32.5mg/325mg tablets 30 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Co-proxamol 32.5mg/325mg tablets (A A H Pharmaceuticals Ltd) 30 tablet Is a True Co-proxamol 32.5mg/325mg tablets 30 tablet Inferred relationship Existential restriction modifier
Co-proxamol 32.5mg/325mg tablets (Alpharma Limited) 30 tablet 3 x 10 tablets Is a True Co-proxamol 32.5mg/325mg tablets 30 tablet Inferred relationship Existential restriction modifier
Co-proxamol 32.5mg/325mg tablets (Zentiva Pharma UK Ltd) 30 tablet 3 x 10 tablets Is a True Co-proxamol 32.5mg/325mg tablets 30 tablet Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start